Anti-ALDOA antibody: a novel diagnostic-associated autoantibody in myasthenia gravis

This study identified novel autoantibodies in patients with seronegative myasthenia gravis (SNMG).Autoantibodies in SNMG sera were screened using a targeted binding assay (TBA). The target antigen was identified via immunoprecipitation and mass spectrometry, and validated by western blotting using a commercial antigen. A cell-based assay (CBA) employing HEK293 cells expressing the identified antigen was established to detect specific antibodies in 676 MG patients and 20 controls.Aldolase A (ALDOA) was identified as a novel autoantigen. Anti-ALDOA antibodies (ALDOA-Ab) demonstrated high diagnostic specificity in SNMG and were also detected in seropositive MG patients, with positivity rates of 4.89% in AChR-Ab' and 2.86% in MuSK-Ab' subgroups. ALDOA-Ab was predominantly of the IgG1 subclass. ALDOA-Ab may serve as a potential diagnostic biomarker for MG. Further studies are needed to investigate its pathogenic role.

Authors

Institutions

Publication Details

Journal
Frontiers in Neurology
Published
2025-10-23
DOI
https://doi.org/10.3389/fneur.2025.1696583
Primary Topic
Myasthenia Gravis and Thymoma
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-ALDOA antibody: a novel diagnostic-associated autoantibody in myasthenia gravis

Xinyue Zhou, Feng Gao, Zhe Ruan, Jia Hu et al.
Frontiers in Neurology
Myasthenia Gravis and Thymoma
article

Anti-ALDOA antibody: a novel diagnostic-associated autoantibody in myasthenia gravis

Xinyue Zhou, Feng Gao, Zhe Ruan, Jia Hu, Ting Chang, Xue Zhao, Yingna Zhang, Qian Liu, Jing Zhang, Peipei Liu, Mengdi Zhang, Junhong Yang, Quanli Gao, Ruichen Liu, Haiyan Dong, Jie Lv, Jing Liu
article en

Abstract

This study identified novel autoantibodies in patients with seronegative myasthenia gravis (SNMG).Autoantibodies in SNMG sera were screened using a targeted binding assay (TBA). The target antigen was identified via immunoprecipitation and mass spectrometry, and validated by western blotting using a commercial antigen. A cell-based assay (CBA) employing HEK293 cells expressing the identified antigen was established to detect specific antibodies in 676 MG patients and 20 controls.Aldolase A (ALDOA) was identified as a novel autoantigen. Anti-ALDOA antibodies (ALDOA-Ab) demonstrated high diagnostic specificity in SNMG and were also detected in seropositive MG patients, with positivity rates of 4.89% in AChR-Ab' and 2.86% in MuSK-Ab' subgroups. ALDOA-Ab was predominantly of the IgG1 subclass. ALDOA-Ab may serve as a potential diagnostic biomarker for MG. Further studies are needed to investigate its pathogenic role.

Frontiers in NeurologyVol. 16
Zhengzhou University (CN), First Affiliated Hospital of Henan University (CN), Air Force Medical University (CN)
Academy of Pharmaceutical Sciences, National Natural Science Foundation of China
Openalex Percentile: Top 57%
Myasthenia Gravis and Thymoma
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.